Neurocrine Biosciences (NBIX) Revenue Growth (1y) (2011 - 2026)
Neurocrine Biosciences (NBIX) Revenue Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 2.34% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 2.91% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -1.62% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 6.98% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 42.25% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 14.92% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -87.11% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.23% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 3.77% |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 4,158.49% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 42.25% |
| Dec 31, 2025 | 28.33% |
| Sep 30, 2025 | 27.78% |
| Jun 30, 2025 | 16.49% |
| Mar 31, 2025 | 11.12% |
| Dec 31, 2024 | 21.84% |
| Sep 30, 2024 | 24.72% |
| Jun 30, 2024 | 30.37% |
| Mar 31, 2024 | 22.57% |
| Dec 31, 2023 | 25.05% |
| Sep 30, 2023 | 28.59% |
| Jun 30, 2023 | 2,163.50% |
| Mar 31, 2023 | 35.35% |
| Dec 31, 2022 | 32.05% |
| Sep 30, 2022 | 31.05% |
| Jun 30, 2022 | -93.08% |
| Mar 31, 2022 | 31.28% |
| Dec 31, 2021 | 25.86% |
| Sep 30, 2021 | 14.51% |
| Jun 30, 2021 | -4.46% |